Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

LifeMD (LFMDP) Return on Equity (2016 - 2025)

Historic Return on Equity for LifeMD (LFMDP) over the last 13 years, with Q3 2025 value amounting to 40.32%.

  • LifeMD's Return on Equity rose 357900.0% to 40.32% in Q3 2025 from the same period last year, while for Sep 2025 it was 40.32%, marking a year-over-year increase of 357900.0%. This contributed to the annual value of 8.2% for FY2024, which is 128400.0% down from last year.
  • Latest data reveals that LifeMD reported Return on Equity of 40.32% as of Q3 2025, which was up 357900.0% from 14.95% recorded in Q2 2025.
  • In the past 5 years, LifeMD's Return on Equity registered a high of 40.32% during Q3 2025, and its lowest value of 92.83% during Q3 2022.
  • For the 5-year period, LifeMD's Return on Equity averaged around 1.9%, with its median value being 1.95% (2023).
  • Per our database at Business Quant, LifeMD's Return on Equity tumbled by -985900bps in 2022 and then soared by 946100bps in 2023.
  • Over the past 5 years, LifeMD's Return on Equity (Quarter) stood at 30.05% in 2021, then skyrocketed by 122bps to 6.76% in 2022, then tumbled by -40bps to 4.03% in 2023, then tumbled by -163bps to 2.54% in 2024, then soared by 1687bps to 40.32% in 2025.
  • Its last three reported values are 40.32% in Q3 2025, 14.95% for Q2 2025, and 4.38% during Q1 2025.